-
Evoke Gets FDA Nod For Gimoti, A Nasally-Administered Gastroparesis Drug
Monday, June 22, 2020 - 9:13am | 457Read More...The binary event that was scheduled for last week panned out in favor of Evoke Pharma Inc (NASDAQ: EVOK). What Happened: The Solana Beach, California-based specialty pharma company said the FDA gave its nod for its Gimoti nasal spray that would allow the company to commercially market it in the U.S...


